- Home
- TLSI vs RTC Comparison
TLSI vs RTC Comparison
Compare TLSI & RTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- RTC
- Stock Information
- Founded
- TLSI 2010
- RTC 2003
- Country
- TLSI United States
- RTC China
- Employees
- TLSI N/A
- RTC N/A
- Industry
- TLSI Medical Specialities
- RTC Specialty Chemicals
- Sector
- TLSI Health Care
- RTC Industrials
- Exchange
- TLSI Nasdaq
- RTC Nasdaq
- Market Cap
- TLSI 124.9M
- RTC 180.6M
- IPO Year
- TLSI N/A
- RTC N/A
- Fundamental
- Price
- TLSI $4.69
- RTC $2.14
- Analyst Decision
- TLSI Strong Buy
- RTC
- Analyst Count
- TLSI 6
- RTC 0
- Target Price
- TLSI $11.75
- RTC N/A
- AVG Volume (30 Days)
- TLSI 36.4K
- RTC 61.0K
- Earning Date
- TLSI 11-14-2024
- RTC 03-13-2025
- Dividend Yield
- TLSI N/A
- RTC N/A
- EPS Growth
- TLSI N/A
- RTC N/A
- EPS
- TLSI N/A
- RTC N/A
- Revenue
- TLSI $26,891,000.00
- RTC $59,794,661.00
- Revenue This Year
- TLSI $60.96
- RTC N/A
- Revenue Next Year
- TLSI $53.65
- RTC N/A
- P/E Ratio
- TLSI N/A
- RTC N/A
- Revenue Growth
- TLSI 67.90
- RTC N/A
- 52 Week Low
- TLSI $3.50
- RTC $1.88
- 52 Week High
- TLSI $10.42
- RTC $40.00
- Technical
- Relative Strength Index (RSI)
- TLSI 51.68
- RTC 19.21
- Support Level
- TLSI $4.72
- RTC $3.26
- Resistance Level
- TLSI $5.32
- RTC $3.17
- Average True Range (ATR)
- TLSI 0.31
- RTC 0.50
- MACD
- TLSI 0.01
- RTC 0.02
- Stochastic Oscillator
- TLSI 47.52
- RTC 8.41
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About RTC Baijiayun Group Ltd.
Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.